Minireview: Nicotinic Acetylcholine Receptors on Hippocampal Neurons: Distribution on the Neuronal Surface and Modulation of Receptor Activity

References

• Nastuk W. L. Membrane potential changes at a single muscle end-plate produced by transitory application of acetylcholine with an electrically controlled microjet. Fed. Proc. 1953; 12: 102
   Google Scholar
• Del Castillo J., Katz B. On the localization of the acetylcholine receptor. J. Physiol. (Lond.) 1955; 128: 157–181
   Google Scholar
• Axelsson J., Thesleff S. A study of the supersensitivity of in denervated mammalian skeletal muscle. J. Physiol. (Lond.) 1959; 147: 178–193
   Google Scholar
• Miledi R. The acetylcholine sensitivity of frog muscle fibers after complete or partial denervation. J. Physiol. (Lond.) 1960; 151: 1–23
   Google Scholar
• Albuquerque E. X., McIsaac R. J. Fast and slow mammalian muscles after denervation. Exp. Neurol. 1970; 26: 183–202
   PubMed Web of Science ®Google Scholar
• Feltz A., Mallart A. An analysis of acetylcholine responses of junctional and extrajunctional receptors of frog muscle fibres. J. Physiol. (Lond.) 1971; 218: 85–100
   Google Scholar
• Schröder H., Giacobini E., Struble R. G., Zilles K., Maelicke A. Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiol. Aging 1991; 12: 259–262
   PubMed Web of Science ®Google Scholar
• Castro N. G., Albuquerque E. X. α-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophys. J. 1995; 68: 516–524
   PubMed Web of Science ®Google Scholar
• Petit T. L. The neurobiology of learning and memory: Elucidation of the mechanisms of cognitive function. NeuroToxicology 1988; 5: 413–428
   Google Scholar
• Lindstrom J. Nicotinic acetylcholine receptors. Handbook of Receptors and Ion Channels, R. Alan North. CRC, Ann Arbor 1995; 153–175
   Google Scholar
• Alkondon M., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 1993; 265: 1455–1473
   PubMed Web of Science ®Google Scholar
• Alkondon M., Reinhardt-Maelicke S., Lobron C., Hermsen B., Maelicke A., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: II. Rundown and inward rectification of agonist-elicited whole-cell currents and in situ hybridization studies. J. Pharmacol. Exp. Ther. 1994; 371: 494–506
   Google Scholar
• Ishihara K., Alkondon M., Montes J. G., Albuquerque E. X. Nicotinic responses in acutely dissociated rat hippocampal neurons and the selective blockade of fast desensitizing nicotinic currents by lead. J. Pharmacol. Exp. Ther. 1995; 273: 1471–1482
   PubMed Web of Science ®Google Scholar
• Barbosa C. T. F., Alkondon M., Aracava Y., Maelicke A., Albuquerque E. X. Ligand-gated ion channels in acutely dissociated rat hippocampal neurons with long dendrites. Neurosci. Lett. 1996; 210: 177–180
   PubMed Web of Science ®Google Scholar
• Bonfante-Cabarcas R., Swanson K. L., Alkondon M., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons IV. Regulation by external Ca2+ of α-bungarotoxin-sensitive receptor function and rectification induced by internal Mg2+. J. Pharmacol. Exp. Ther. 1996; 277: 432–444
   PubMed Web of Science ®Google Scholar
• Barrantes G. E., Rogers A. T., Lindstrom J., Wonnacott S. Alpha-bungarotoxin binding sites in hippocampal and cortical cultures: Initial characterisation, colocalisation with alpha7 subunits and up-regulation by chronic nicotinic treatment. Brain Res. 1995; 672: 228–236
   PubMed Web of Science ®Google Scholar
• Johnson J., Ascher P. Equilibrium and kinetic study of glycine action on the NMDA receptor in cultured mouse brain neurons. J. Physiol. (Lond.) 1992; 455: 339–365
   Google Scholar
• Alkondon M., Pereira E. F. R., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors (nAChRs) in rat brain. VI. Mapping the location of functional nAChRs on hippocampal neurons of the rat. J. Pharmacol. Exp. Ther., submitted
   Google Scholar
• Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 1991; 391: 85–100
   Google Scholar
• Schröder H. Monoclonal antibodies reveal the cellular localization and expression of cortical nicotinic and muscarinic cholinoceptors in human cerebral cortex. Prog. Hist. Cytochem. 1992; 26: 266–270
   PubMedGoogle Scholar
• Pereira E. F. R., Reinhardt-Maelicke S., Schrattenholz A., Maelicke A., Albuquerque E. X. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 1993; 265: 1474–1491
   PubMed Web of Science ®Google Scholar
• Nicoll R. A., Kauer J. A., Malenka R. C. The current excitement in long-term potentiation. Neuron 1988; 1: 97–103
   PubMed Web of Science ®Google Scholar
• Wigstrom H., Gustafsson B. Long-Term Potentiation: From Biophysics to Behavior, P. W. Landfield, S. A. Deadwyler. Liss, NY 1988; 3–72
   Google Scholar
• Regehr W. G., Tank D. W. Postsynaptic NMDA receptor-mediated calcium accumulation in hippocampal CA1 pyramidal cell dendrites. Nature 1990; 345: 807–805
   PubMed Web of Science ®Google Scholar
• Westenbroek R. E., Ahlijanian M. K., Cattrall W. A. Clustering of L-type Ca2+ channels at the base of major dendrites in hippocampal pyramidal neurons. Nature 1990; 347: 281–284
   PubMed Web of Science ®Google Scholar
• Alkondon M., Rocha E. S., Maelicke A., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in brain neurons. V. α-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons, and presynaptic modulation of glutamate release. J. Pharmacol. Exp. Ther. 1996, in press
   Web of Science ®Google Scholar
• Hunt S. P., Schmidt J. The electron microscopic autoradiographic location of α-bungarotoxin binding sites within the central nervous system of the rat. Brain Res. 1978; 142: 152–159
   PubMed Web of Science ®Google Scholar
• Castro N. G., Albuquerque E. X. Brief-lifetime, fast-inactivating ion channels account for the α-bungarotoxin-sensitive nicotinic response in hippocampal neurons. Neurosci. Lett. 1993; 164: 137–140
   PubMed Web of Science ®Google Scholar
• Bading H., Ginty D. D., Greenberg M. E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993; 260: 181–186
   PubMed Web of Science ®Google Scholar
• Frotscher M. Application of the Golgi/electronmicroscopy technique for cell identification in immunocytochemical retrograde labeling and developmental studies of hippocampal neurons. Microsc. Res. Tech. 1992; 23: 306–323
   PubMed Web of Science ®Google Scholar
• Nowak L., Bregestowski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 1984; 307: 462–465
   PubMed Web of Science ®Google Scholar
• Brocard J. B., Rajdev S., Reynolds L. J. Glutamate-induced increases in intracellular free Mg2+ in cultured cortical neurons. Neuron 1995; 11: 751–757
   Web of Science ®Google Scholar
• Williams K., Hanna J. L., Molinoff P. B. Developmental changes in the sensitivity of the N-methyl-d-aspartate receptor to polyamines. Mol. Pharmacol. 1991; 40: 774–782
   PubMed Web of Science ®Google Scholar
• Huettner J. E., Bean B. P. Block of N-methyl-d-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc. Natl. Acad. Sci. USA 1988; 85: 1307–1311
   PubMed Web of Science ®Google Scholar
• Peters S., Koh J., Choi D. W. Zinc selectively blocks the action of N-methyl-d-aspartate on cortical neurons. Science 1987; 236: 589–593
   PubMed Web of Science ®Google Scholar
• Majewska P. Neurosteroids: Endogenous bimodal modulators of GABAA receptors. Mechanism of action and physiological significance. Prog. Neurobiol. 1992; 38: 379–385
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Gage P. W. Differential effects of perhydro-histrionicotoxin on neurally and iontophoretically evoked endplate currents. Proc. Natl. Acad. Sci. USA 1978; 75: 1596–1599
   PubMed Web of Science ®Google Scholar
• Albuquerque E. X., Pereira E. F. R., Castro N. G., Alkondon M. Neuronal nicotinic receptors: Function, modulation, and structure. Seminars in the Neurosci. 1995; 7: 91–101
   Web of Science ®Google Scholar
• Maelicke A., Schrattenholz A., Storch A., Schroder B., Gutbrod O., Methfessel C., Weber K. H., Pereira E. F. R., Alkondon M., Albuquerque E. X. Noncompetitive agonism at nicotinic acetylcholine receptors: Functional significance for CNS signal transduction. J. Receptor & Signal Transduction Res. 1995; 15: 333–353
   PubMed Web of Science ®Google Scholar
• Okonjo K. O., Kuhlmann J., Maelicke A. A second pathway for the activation of the Torpedo acetylcholine receptor. Eur. J. Biochem. 1991; 200: 671–677
   PubMedGoogle Scholar
• Pereira E. F. R., Alkondon M., Reinhardt-Maelicke S., Maelicke A., Peng X., Lindstrom J., Whiting P., Albuquerque E. X. Physostigmine and galanthamine: Probes for a novel binding site on the α4β2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells. J. Pharmacol. Exp. Ther. 1994; 270: 768–778
   PubMed Web of Science ®Google Scholar
• Storch A., Schrattenholz A., Cooper J. C., Ghani E. M. A., Gutbrod O., Weber K.-H., Reinhardt S., Lobron C., Hermsen B., Soskiç V., Pereira E. F. R., Albuquerque E. X., Methfessel C., Maelicke A. Physostigmine, galanthamine and codeine act as non-competitive agonists on clonal rat pheochromocytoma cells. Eur. J. Pharmacol. 1995; 290: 207–219
   PubMed Web of Science ®Google Scholar
• Pereira E. F. R., Alkondon M., Tano T., Castro N. G., Fróes-Ferrão M. M., Rozental R., Aronstam R. S., Schrattenholz A., Maelicke A., Albuquerque E. X. A novel agonist binding site on nicotinic acetylcholine receptors. J. Receptor Res. 1993; 13: 413–436
   PubMed Web of Science ®Google Scholar
• Schrattenholz A., Pereira E. F. R., Methfessel C., Roth U., Weber K.-H., Albuquerque E. X., Maelicke A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 1996; 49: 1–6
   PubMed Web of Science ®Google Scholar
• Wright C. I., Guela C., Mesulam M. M. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 1993; 90: 683–686
   PubMed Web of Science ®Google Scholar
• Garcia-Colunga J., Miledi R. Effects of serotoninergic agents on neuronal nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. USA 1995; 92: 2919–2923
   PubMed Web of Science ®Google Scholar
• Molliver M. E. Serotoninergic neuronal systems: What their anatomic organization tells us about function. J. Clin. Psychopharmacol. 1987; 7: 3S–23
   PubMed Web of Science ®Google Scholar
• Maura G., Carbone R., Guido M., Pestarino M., Raiteri M. 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. Eur. J. Pharmacol. 1991; 202: 185–190
   PubMed Web of Science ®Google Scholar
• Shupliakov O., Pieribone V. A., Gad H., Brodin L. Synaptic vesicle depletion in reticulospinal axons is reduced by 5-hydroxytryptamine: Direct evidence for presynaptic modulation of glutamatergic transmission. Eur. J. Neurosci. 1995; 7: 1111–1116
   PubMed Web of Science ®Google Scholar
• McGehee D. S., Heath M. J. S., Gelber S., Devay P., Role L. W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 1995; 269: 1692–1696
   PubMed Web of Science ®Google Scholar